🇺🇸 FDA

Drug profile · INN

polyethylene glycol 3350

POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

polyethylene glycol 3350 (POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN polyethylene glycol 3350
Brand POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL
Route ORAL
Formulation FOR SUSPENSION
Originator Teva Pharma GmbH

Frequently asked questions

What is polyethylene glycol 3350?

polyethylene glycol 3350 (POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for polyethylene glycol 3350?

POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL is a marketed brand name for polyethylene glycol 3350. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of polyethylene glycol 3350?

polyethylene glycol 3350 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.